-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 15, Yiling Pharmaceutical announced that recently, the company received a botanical registration approval document approved and issued by the Pharmacy and Poisons Administration of the Ministry of Health of Kenya, approving the company's drug Lianhua Qingwen Capsule to comply with the Kenya Botanical Standard Registration.
Lianhuaqingwen products to Ridge's main product, the national essential drugs list and national medical insurance catalog (CPI) varieties, mainly used in the treatment of colds, influenza-related illness.
For the treatment of colds and flu-related diseases.
In the first three quarters, Lianhua Qingwen products achieved operating income of 2.
871 billion yuan, accounting for 44.
52% of the company's total operating income.